Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability
暂无分享,去创建一个
M. I. Khan | M. Sohail | S. Raza | O. S. Qureshi | G. Shahnaz | M. Sajjad | Sana Ijaz | Sara Naveed
[1] Hamid Hamedi,et al. Chitosan based hydrogels and their applications for drug delivery in wound dressings: A review. , 2018, Carbohydrate polymers.
[2] I. Hussain,et al. Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral delivery of Docetaxel , 2018, Scientific Reports.
[3] M. Devereux,et al. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry. , 2018, Current medicinal chemistry.
[4] T. Webster,et al. Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends , 2018, International journal of nanomedicine.
[5] Ali Khademhosseini,et al. Evolution and Clinical Translation of Drug Delivery Nanomaterials. , 2017, Nano today.
[6] S. Akhtar,et al. Folate grafted thiolated chitosan enveloped nanoliposomes with enhanced oral bioavailability and anticancer activity of docetaxel. , 2016, Journal of materials chemistry. B.
[7] I. Hussain,et al. Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B. , 2015, Journal of materials chemistry. B.
[8] Guihua Fang,et al. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. , 2015, Molecular pharmaceutics.
[9] Kanika Thakur,et al. Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies. , 2014, International journal of biological macromolecules.
[10] Yan Huang,et al. Facile preparation of fluorescent Ag-clusters–chitosan-hybrid nanocomposites for bio-applications , 2014 .
[11] A. Alomrani,et al. Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability , 2013, International journal of nanomedicine.
[12] M. Bhatia,et al. Polymers influencing transportability profile of drug. , 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[13] A. Bernkop‐Schnürch,et al. Enzymatic degradation of thiolated chitosan , 2013, Drug development and industrial pharmacy.
[14] S. Ostad,et al. Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies , 2013, BioMed research international.
[15] P. Dong,et al. Emerging Therapeutic Biomarkers in Endometrial Cancer , 2013, BioMed research international.
[16] Lingrong Liu,et al. Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer , 2013, Nanoscale Research Letters.
[17] J. Iqbal,et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. , 2012, International journal of pharmaceutics.
[18] Xiao-rong Li,et al. Research progress on siRNA delivery with nonviral carriers , 2011, International journal of nanomedicine.
[19] S. Ostad,et al. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation , 2011, International journal of nanomedicine.
[20] A. Bernkop‐Schnürch,et al. Synthesis, characterization, mucoadhesion and biocompatibility of thiolated carboxymethyl dextran-cysteine conjugate. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[21] S. Jon,et al. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[22] Jin Sun,et al. Preparation and Characterization of a Submicron Lipid Emulsion of Docetaxel: Submicron Lipid Emulsion of Docetaxel , 2008, Drug development and industrial pharmacy.
[23] P. Kintzel,et al. Docetaxel‐Associated Epiphora , 2006, Pharmacotherapy.
[24] Philip S Low,et al. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. , 2005, Journal of pharmaceutical sciences.
[25] G. Hortobagyi,et al. Docetaxel for treatment of solid tumours: a systematic review of clinical data. , 2005, The Lancet. Oncology.
[26] A. Bernkop‐Schnürch,et al. Synthesis and in vitro evaluation of a novel thiolated chitosan. , 2005, Biomaterials.
[27] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[28] T. Meade,et al. Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. , 1995, Bioconjugate chemistry.
[29] L R Coney,et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.
[30] D. Guénard,et al. Relationships between the structure of taxol analogues and their antimitotic activity. , 1991, Journal of medicinal chemistry.
[31] I. Ringel,et al. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. , 1991, Journal of the National Cancer Institute.
[32] Ihab I. Al-khalifa,et al. Preparation, In Vitro and In Vivo Studies of Vitamin B12 Loaded Implants , 2020 .
[33] Javed Iqbal,et al. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] J. Fernandes,et al. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[35] J. Schellens,et al. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093) , 2004, Cancer Chemotherapy and Pharmacology.